ABSTRACT
Chemoradiotherapy is increasingly used in advanced laryngeal cancers. Failures are generally managed by surgery. They include histologically confirmed recurrent or residual disease or a symptomatic life threatening treatment sequelae. Tumour recurrence or residivism can be managed by chemotherapy when radical surgery is either refused by the patient or if the general condition of the patient do not permit it. However surgery becomes inevitable when life threatening treatment sequelae like absolute pharyngo-oesophageal stricture and aspiration sets in.
Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/radiotherapy , Combined Modality Therapy , Esophageal Stenosis/etiology , Humans , Laryngeal Neoplasms/radiotherapy , Male , Methotrexate/therapeutic use , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Neoplasms, Radiation-Induced/drug therapy , Salvage Therapy , Treatment OutcomeABSTRACT
Neoplasms of the chest wall are not uncommon. Majority of the tumours occurring in the chest wall are benign. The tumours may arise from the soft tissues,connective tissues or bone. Metastatic tumours can arise as a result of direct infiltration or haematogenous spread. The management of these tumours is challenging. Resection of the chest wall with or without the excision of ribs, require reconstruction not only for aesthetic reasons but also for providing the stability to the chest wall which is of prime importance in maintaining the respiratory functions. In this article, 46 cases of the primary malignant chest wall tumours seen over a period of 5 years are reviewed.